Pharmacokinetics of technetium-99m diphosphonate

Area of Science:

• Nuclear medicine
• Radiopharmacology
• Medical imaging

Background:

• Bone scintigraphy is crucial for diagnosing skeletal abnormalities.
• Technetium-99m diphosphonate (Tc-99m) is a widely used radiotracer for bone scans.
• Detailed kinetic analysis may enhance diagnostic information from bone scans.

Purpose of the Study:

• To investigate the diagnostic value of kinetic analysis of Tc-99m diphosphonate.
• To correlate blood disappearance, urinary excretion, and skeletal uptake with scan findings.
• To differentiate between normal and diseased bone uptake patterns.

Main Methods:

• Quantitative analysis of blood disappearance and urinary excretion of Tc-99m diphosphonate in normal volunteers and patients.
• Scintillation camera imaging with computer interfacing for quantitative assessment of skeletal uptake.
• Kinetic modeling of tracer distribution in blood, urine, and bone.

Main Results:

• Blood Tc-99m levels showed a triexponential clearance pattern.
• Significant differences in 5-minute blood and 0-1 hour urine values were observed between patient groups (p < 0.05).
• Quantitative imaging revealed distinct patterns of Tc-99m uptake and clearance in bone, kidneys, and soft tissues, differing between normal and diseased bone.

Conclusions:

• Kinetic analysis of Tc-99m diphosphonate provides valuable diagnostic information beyond standard bone scans.
• Blood and urine excretion kinetics, along with quantitative skeletal uptake, can help differentiate normal from abnormal bone.
• This approach offers a more detailed assessment of bone pathology using Tc-99m scintigraphy.